| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $351.4M | -20.6% |
| R&D Expense | $111.4M | -4.0% |
| SG&A Expense | $144.3M | -8.9% |
| Operating Income | $93.1M | +109.8% |
| Pre-tax Income | $65.2M | +106.9% |
| Income Tax | $64.3M | -23.0% |
| Net Income | $880K | +100.1% |
| EPS (Basic) | $0.01 | +100.2% |
| EPS (Diluted) | $0.01 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.6M | -3.9% |
| Accounts Receivable | $81.9M | -36.6% |
| Current Assets | $182.4M | -21.8% |
| Total Assets | $350.9M | -25.5% |
| Current Liabilities | $38.8M | -85.9% |
| Stockholders' Equity | -$301.3M | +13.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $103.5M | -43.5% |
| Capital Expenditures | $142K | -48.0% |
| Investing Cash Flow | -$142K | +100.0% |
| Financing Cash Flow | -$107.0M | -138.6% |
| Free Cash Flow | $103.4M | -43.5% |
| +100.2% |